Notice to all Authorized Local Agents,

This is to kindly inform all authorized local agents that, as discussed with the members of the SLCPI and the Pricing Committee, the NMRA will consider the average dollar rate of the previous three months for price approvals of Maximum Retail Prices (MRPs) of medicines from January 2025 onwards.

Accordingly for the month of March 2025, the corrected United States Dollar (USD) rate considered for pricing calculation is 298.01 for reviewing price details of medicines. All the prices recommended by using prevously published exchange rate, shall be recalculated and corrected.

We are apologizing for the inconvenience occurred on this.

This decision aims to ensure fair and consistent pricing of medicines while considering the fluctuations in the exchange rate. Please ensure that all price submissions for MRP approvals are prepared accordingly.